Skip to main content
Fig. 1 | BMC Cardiovascular Disorders

Fig. 1

From: Plasma calprotectin was associated with platelet activation and no-reflow phenomenon in acute coronary syndrome

Fig. 1

Comparison of calprotectin and PMA between ACS patients with and without no-reflow. a ACS patients with no-reflow had higher PMA (47.58 ± 12.30% vs 36.73 ± 12.55%, ***p < 0.001) and (b) higher plasma calprotectin (6062.9 ± 999.8 vs 3625.7 ± 1526.8 ng/mL, ***p < 0.001) compared with those without no-reflow. Data are means ± SD

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us